Catalyst Wire Dossier Catalyst Wire Dossier

Teriparatide (Forteo)

teriparatide · Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Teriparatide (Forteo), covering 2012-12-28 to 2017-05-08. Get the full timeline:

Most recent: Clinical Trial Update: Teriparatide (Forsteo) Treatment in Postmenopausal Women: Mechanism of Action [Phase 4]

See pricing